Heterocyclic ITK inhibitors for treating inflammation and cancer
First Claim
Patent Images
1. A compound, or a pharmaceutically acceptable salt, hydrate or solvate thereof, of Formula (I):
3 Assignments
0 Petitions
Accused Products
Abstract
Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I):
wherein R1, R2, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
23 Citations
7 Claims
- 1. A compound, or a pharmaceutically acceptable salt, hydrate or solvate thereof, of Formula (I):
Specification